City Therapeutics logo

Sr. Scientist/Pr. Scientist, Drug Product Formulation and Development

City Therapeutics

Cambridge, MAOnsitePosted 1 day ago$135,000 - $160,000/year
Full TimeSenior LevelManufacturing & CMCBiotechnology
Original posting ↗

Summary

CMC is actively seeking an enthusiastic and highly motivated scientist responsible for parenteral oligonucleotide formulation development. The successful candidate will serve as a Drug Product (DP) subject matter expert, responsible for formulation development, manufacturing process development, stability assessment, and technical oversight of external CDMOs. This role requires strong scientific expertise in oligonucleotide therapeutics, particularly siRNA, combined with relevant knowledge of sterile injectable drug products, and GMP manufacturing.

Job description

Key Responsibilities

  • Acting as technical representative in a cross functional team to support drug product formulation development/characterizations, fill/finish process development/characterizations, technology transfer
  • Authoring/co-authoring and reviewing guideline documents, technical protocols, reports, process control strategy, risk assessments, and CMC regulatory filings for IND and marketing applications
  • Driving continuous improvement in DP formulation development process through technological advancements/innovations
  • Delivering progress reports and presentations to promote management awareness and engagement of the status, progress, and future program and functional needs
  • Working effectively in a highly matrixed team environment to advance programs, inspire change, improve efficiency, and foster positive relationships
  • Demonstrated leadership to work with multi-functional teams and dynamic environment at a fast pace to achieve timely deliverables
  • Team leader overseeing and participating in the planning, design, implementation and documentation of formulation development and fill/finish process development studies to support drug product platform development strategy
  • Work closely with CMC Leads, Drug Substance Development, Analytical Development, and Quality Assurance
  • Contribute to the development of scientific best practices and continuous improvement initiatives

Qualifications

  • Scientist: B.S. (+8-10 years), M.S. (+6-8 years), or PhD (+2-5 years) in Pharmaceutical Industry, Biotechnology, Material Science, Engineering, Chemistry or related subject area
  • Scientist: B.S. (+10 years), M.S. (+8 years), or PhD (+5 years) in Pharmaceutical Industry, Biotechnology, Material Science, Engineering, Chemistry or related subject area
  • Hands-on experience in oligonucleotide or biologics parenteral formulation, fill/finish process development, process characterization, technical transfers to manufacturing sites or CMOs, and DoE studies and regulatory authoring
  • Good knowledge of formulation, aseptic processing, sterility assurance, statistic modeling, regulatory filings
  • Knowledge of, and hands-on experience with nanoparticle and/or medical device delivery systems is a plus
  • Familiarity with GMP manufacturing, technical documentation, and regulatory requirements for clinical drug products is a plus
  • Strong problem solving, effective multi-functional communication skills and excellent organization skills

Requirements

  • B.S. (+8-10 years), M.S. (+6-8 years), or PhD (+2-5 years) in Pharmaceutical Industry, Biotechnology, Material Science, Engineering, Chemistry or related subject area
  • Hands-on experience in oligonucleotide or biologics parenteral formulation, fill/finish process development, process characterization, technical transfers to manufacturing sites or CMOs, and DoE studies and regulatory authoring
  • Good knowledge of formulation, aseptic processing, sterility assurance, statistic modeling, regulatory filings
  • Strong problem solving, effective multi-functional communication skills and excellent organization skills
  • Knowledge of, and hands-on experience with nanoparticle and/or medical device delivery systems is a plus
  • Familiarity with GMP manufacturing, technical documentation, and regulatory requirements for clinical drug products is a plus

Benefits

  • Annual Bonus
  • Equity Compensation
  • Competitive Benefits Package

Company overview

City Therapeutics is a pioneering biotechnology company focused on advancing next-generation RNA interference (RNAi) therapeutics. Founded in 2024 by leading executives and scientists from the RNAi field, including former Alnylam Pharmaceuticals CEO John Maraganore, the company is headquartered in Cambridge, Massachusetts. City Therapeutics specializes in engineering small interfering RNAs (siRNAs) to create innovative medicines that can silence gene expression and block protein production for treating various diseases. The company has raised $135 million in Series A funding from prominent investors including ARCH Venture Partners, Fidelity Management & Research Company, and Regeneron Ventures. City Therapeutics is developing a sustainable product engine for RNAi-based medicines, with its lead program CITY-FXI targeting Factor XI for thromboembolic diseases expected to enter clinical trials. The company's platform focuses on designing novel RNAi triggers with improved potency and specificity, developing tailored targeting ligands for broader tissue delivery, and creating best-in-class molecules to expand RNAi's therapeutic reach beyond the liver to address ocular, CNS, and other tissue types.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.